AIHealthcare

AI-in-Healthcare Intelligence Platform

Pfizer

Healthcare and biopharmaceuticals AI-enabled drug discovery, clinical development, manufacturing, and patient engagement Public

Pfizer Inc. is a U.S.-based global biopharmaceutical company developing and commercializing medicines and vaccines. In healthcare AI, Pfizer applies artificial intelligence and machine learning across drug discovery, clinical-trial recruitment, medical writing, manufacturing, supply forecasting, commercial operations, and patient engagement. Its disclosed examples include the AI-powered OncoScout platform for oncology compound prioritization, AI-assisted identification of clinical-trial candidates, and an internal Medical AI Assistant. Pfizer reported $63.6 billion in 2024 revenue and described AI as a strategic source of R&D productivity and operational efficiency. The company has stated an ambition to become the most AI-forward company in its industry, but no independently verified AI-specific market-share figure or recent external AI-healthcare financing round was identified.

Company Details

Website
pfizer.com
Headquarters
New York City, New York, United States
Founded
1849

Subscriber Intelligence

  • • Deal signal alerts for this company
  • • Sentiment & risk scoring
  • • Competitive framework analysis
  • • Regulatory event monitoring
← Back to Company Directory